LABORATORY VALUES

U.S. traditional units are followed in parentheses by equivalent values expressed in S.I. units.

Hematology High-density lipoprotein (HDL) — greater than or equal

to 40 mg/dL (1.04 mmol/L), desirable
Absolute neutrophil count Complement, serum
Male — 1780-5380/µL (1.78-5.38 x 109/L) C3 — 55-120 mg/dL (550-1200 mg/L)
Female — 1560-6130/µL (1.56-6.13 x 109/L) Total (CH50) — 37-55 U/mL (37-55 kU/L)
Activated partial thromboplastin time — 25-35 s Creatine kinase, serum — 30-170 units/L
Bleeding time — less than 10 min Creatinine, serum — 0.7-1.3 mg/dL (61.9-115 µmol/L)
Erythrocyte count — 4.2-5.9 x 106/µL (4.2-5.9 x 1012/L) Electrolytes, serum
Erythrocyte sedimentation rate Sodium — 136-145 meq/L (136-145 mmol/L)
Male — 0-15 mm/h Potassium — 3.5-5.0 meq/L (3.5-5.0 mmol/L)
Female — 0-20 mm/h Chloride — 98-106 meq/L (98-106 mmol/L)
Erythropoietin — less than 30 mU/mL (30 units/L) Bicarbonate — 23-28 meq/L (23-28 mmol/L)
D-Dimer — less than 0.5 µg/mL (0.5 mg/L) Fibrinogen, plasma — 150-350 mg/dL (1.5-3.5 g/L)
Ferritin, serum — 15-200 ng/mL (15-200 µg/L) Folate, red cell — 160-855 ng/mL (362-1937 nmol/L)
Haptoglobin, serum — 50-150 mg/dL (500-1500 mg/L) Folate, serum — 2.5-20 ng/mL (5.7-45.3 nmol/L)
Hematocrit Glucose, plasma — fasting, 70-100 mg/dL (3.9-5.6 mmol/L)
Male — 41%-51% γ-Glutamyltransferase, serum — 0-30 units/L
Female — 36%-47% Homocysteine, plasma
Hemoglobin, blood Male — 0.54-2.16 mg/L (4-16 µmol/L)
Male — 14-17 g/dL (140-170 g/L) Female — 0.41-1.89 mg/L (3-14 µmol/L)
Female — 12-16 g/dL (120-160 g/L) Immunoglobulins
Leukocyte alkaline phosphatase — 15-40 mg of phosphorus Globulins, total — 2.5-3.5 g/dL (25-35 g/L)
liberated/h per 1010 cells; score = 13-130/100 IgG — 640-1430 mg/dL (6.4-14.3 g/L)
polymorphonuclear neutrophils and band forms IgA — 70-300 mg/dL (0.7-3.0 g/L)
Leukocyte count — 4000-10,000/µL (4.0-10 x 109/L) IgM — 20-140 mg/dL (0.2-1.4 g/L)
Mean corpuscular hemoglobin — 28-32 pg IgD — less than 8 mg/dL (80 mg/L)
Mean corpuscular hemoglobin concentration — 32-36 IgE — 0.01-0.04 mg/dL (0.1-0.4 mg/L)
g/dL (320-360 g/L) Iron studies
Mean corpuscular volume — 80-100 fL Ferritin, serum — 15-200 ng/mL (15-200 µg/L)
Platelet count — 150,000-350,000/µL (150-350 x 109/L) Iron, serum — 60-160 µg/dL (11-29 µmol/L)
Prothrombin time — 11-13 s Iron-binding capacity, total, serum — 250-460 µg/dL
Reticulocyte count — 0.5%-1.5% of erythrocytes; absolute: (45-82 µmol/L)
23,000-90,000/µL (23-90 x 109/L) Transferrin saturation — 20%-50%
Lactate dehydrogenase, serum — 60-100 units/L
Blood, Plasma, and Serum Lactic acid, venous blood — 6-16 mg/dL (0.67-1.8 mmol/L)
Chemistry Studies Lipase, serum — less than 95 units/L
Magnesium, serum — 1.5-2.4 mg/dL (0.62-0.99 mmol/L)
Albumin, serum — 3.5-5.5 g/dL (35-55 g/L) Methylmalonic acid, serum — 150-370 nmol/L
Alkaline phosphatase, serum — 36-92 units/L Osmolality, plasma — 275-295 mosm/kg H2O
α-Fetoprotein, serum — 0-20 ng/mL (0-20 µg/L) Phosphatase, alkaline, serum — 36-92 units/L
Aminotransferase, alanine (ALT) — 0-35 units/L Phosphorus, serum — 3-4.5 mg/dL (0.97-1.45 mmol/L)
Aminotransferase, aspartate (AST) — 0-35 units/L Potassium, serum — 3.5-5.0 meq/L (3.5-5.0 mmol/L)
Ammonia, plasma — 40-80 µg/dL (23-47 µmol/L) Prostate-specific antigen, serum – less than 4 ng/mL
Amylase, serum — 0-130 units/L (4 µg/L)
Bicarbonate, serum — 23-28 meq/L (23-28 mmol/L) Protein, serum
Bilirubin, serum Total — 6.0-7.8 g/dL (60-78 g/L)
Total — 0.3-1.2 mg/dL (5.1-20.5 µmol/L) Albumin — 3.5-5.5 g/dL (35-55 g/L)
Direct — 0-0.3 mg/dL (0-5.1 µmol/L) Globulins, total — 2.5-3.5 g/dL (25-35 g/L)
Blood gases, arterial (ambient air) Rheumatoid factor — less than 40 U/mL (40 kU/L)
pH — 7.38-7.44 Sodium, serum — 136-145 meq/L (136-145 mmol/L)
Pco2 — 35-45 mm Hg (4.7-6.0 kPa) Transferrin saturation — 20%-50%
Po2 — 80-100 mm Hg (10.6-13.3 kPa) Triglycerides — less than 150 mg/dL (1.69 mmol/L),
Oxygen saturation — 95% or greater desirable
Blood urea nitrogen — 8-20 mg/dL (2.9-7.1 mmol/L) Troponins, serum
C-reactive protein — 0.0-0.8 mg/dL (0.0-8.0 mg/L) Troponin I — 0-0.5 ng/mL (0-0.5 µg/L)
Calcium, serum — 9-10.5 mg/dL (2.2-2.6 mmol/L) Troponin T — 0-0.10 ng/mL (0-0.10 µg/L)
Carbon dioxide, serum — See Bicarbonate Urea nitrogen, blood — 8-20 mg/dL (2.9-7.1 mmol/L)
Chloride, serum — 98-106 meq/L (98-106 mmol/L) Uric acid, serum — 2.5-8 mg/dL (0.15-0.47 mmol/L)
Cholesterol, plasma Vitamin B12, serum — 200-800 pg/mL (148-590 pmol/L)
Total — 150-199 mg/dL (3.88-5.15 mmol/L), desirable
Low-density lipoprotein (LDL) — less than or equal to
130 mg/dL (3.36 mmol/L), desirable
Endocrine Triiodothyronine, serum (T3) — 70-195 ng/dL
(1.1-3.0 nmol/L)
Adrenocorticotropic hormone (ACTH), serum — 9-52 Vanillylmandelic acid, urine — less than 8 mg/24 h
pg/mL (2-11 pmol/L) (40.4 µmol/24 h)
Aldosterone, serum Vitamin D
Supine — 2-5 ng/dL (55-138 pmol/L) 1,25-dihydroxy, serum — 25-65 pg/mL (60-156 pmol/L)
Standing — 7-20 ng/dL (194-554 pmol/L) 25-hydroxy, serum — 25-80 ng/mL (62-200 nmol/L)
Aldosterone, urine — 5-19 µg/24 h (13.9-52.6 nmol/24 h)
Catecholamines
Epinephrine, plasma (supine) — less than 75 ng/L (410 Urine
pmol/L) Albumin-creatinine ratio — less than 30 mg/g
Norepinephrine, plasma (supine) — 50-440 ng/L (296- Calcium — 100-300 mg/24 h (2.5-7.5 mmol/24 h) on
2600 pmol/L) unrestricted diet
Catecholamines, 24-hour, urine — less than 100 µg/m2 Creatinine — 15-25 mg/kg per 24 h (133-221 mmol/kg per
per 24 h (591 nmol/m2 per 24 h) 24 h)
Cortisol, free, urine – less than 50 µg/24 h (138 nmol/24 h) Glomerular filtration rate (GFR)
Dehydroepiandrosterone sulfate (DHEA), plasma Normal
Male — 1.3-5.5 µg/mL (3.5-14.9 µmol/L) Male — 130 mL/min/1.73 m2
Female — 0.6-3.3 µg/mL (1.6-8.9 µmol/L) Female — 120 mL/min/1.73 m2
Epinephrine, plasma (supine) — less than 75 ng/L (410 Stages of Chronic Kidney Disease
pmol/L) Stage 1 — greater than or equal to 90 mL/min/1.73 m2
Estradiol, serum Stage 2 — 60-89 mL/min/1.73 m2
Male — 10-30 pg/mL (37-110 pmol/L); Stage 3 — 30-59 mL/min/1.73 m2
Female — day 1-10, 14-27 pg/mL (50-100 pmol/L); day 11- Stage 4 — 15-29 mL/min/1.73 m2
20, 14-54 pg/mL (50-200 pmol/L); day 21-30, 19-41 pg/mL Stage 5 — less than 15 mL/min/1.73 m2
(70-150 pmol/L) 5-Hydroxyindoleacetic acid (5-HIAA) — 2-9 mg/24 h
Follicle-stimulating hormone, serum (10.4-46.8 µmol/24 h)
Male (adult) — 5-15 mU/mL (5-15 units/L) Protein–creatinine ratio – less than or equal to 0.2 mg/mg
Female — follicular or luteal phase, 5-20 mU/mL (5-20 Sodium — 100-260 meq/24 h (100-260 mmol/24 h)
units/L); midcycle peak, 30-50 mU/mL (30-50 units/L); (varies with intake)
postmenopausal, greater than 35 mU/mL (35 units/L) Uric acid — 250-750 mg/24 h (1.48-4.43 mmol/24 h)
Growth hormone, plasma — after oral glucose: less than 2 (varies with diet)
ng/mL (2 µg/L); response to provocative stimuli: greater
than 7 ng/mL (7 µg/L) Gastrointestinal
Luteinizing hormone, serum
Male — 3-15 mU/mL (3-15 units/L) Gastrin, serum — 0-180 pg/mL (0-180 ng/L)
Female — follicular or luteal phase, 5-22 mU/mL (5-22 Stool fat — less than 5 g/d on a 100-g fat diet
units/L); midcycle peak, 30-250 mU/mL (30-250 units/L); Stool weight — less than 200 g/d
postmenopausal, greater than 30 mU/mL (30 units/L)
Metanephrine, urine — less than 1.2 mg/24 h (6.1 mmol/ Pulmonary
24 h) Forced expiratory volume in 1 second (FEV1) — greater
Norepinephrine, plasma (supine) — 50-440 ng/L (296-2600 than 80% of predicted
pmol/L) Forced vital capacity (FVC) — greater than 80% of
Parathyroid hormone, serum — 10-65 pg/mL (10-65 ng/L) predicted
Progesterone, blood FEV1/FVC — greater than 75%
Male (adult) — 0.27-0.9 ng/mL (0.9-2.9 nmol/L)
Female —
follicular phase, 0.33-1.20 ng/mL (1.0-3.8 nmol/L); Cerebrospinal Fluid
luteal phase, 0.72-17.8 ng/mL (2.3-56.6 nmol/L); Cell count — 0-5/µL (0-5 x 106/L)
postmenopausal, <0.2-1 ng/mL (0.6-3.18 nmol/L); Glucose — 40-80 mg/dL (2.2-4.4 mmol/L); less than 40% of
oral contraceptives, 0.34-0.92 ng/mL (1.1-2.9 nmol/L) simultaneous plasma concentration is abnormal
Prolactin, serum Pressure (opening) — 70-200 mm H2O
Male — less than 15 ng/mL (15 µg/L) Protein — 15-60 mg/dL (150-600 mg/L)
Female — less than 20 ng/mL (20 µg/L)
Testosterone, serum Hemodynamic Measurements
Male (adult) — 300-1200 ng/dL (10-42 nmol/L)
Female — 20-75 ng/dL (0.7-2.6 nmol/L) Cardiac index — 2.5-4.2 L/min/m2
Thyroid function tests Left ventricular ejection fraction — greater than 55%
Thyroid iodine (131I) uptake — 10%-30% of administered Pressures
dose at 24 h Pulmonary artery
Thyroid-stimulating hormone (TSH) — 0.5-5.0 µU/mL Systolic — 20-25 mm Hg
(0.5-5.0 mU/L) Diastolic — 5-10 mm Hg
Thyroxine (T4), serum Mean — 9-16 mm Hg
Total — 5-12 µg/dL (64-155 nmol/L) Pulmonary capillary wedge — 6-12 mm Hg
Free — 0.9-2.4 ng/dL (12-31 pmol/L) Right atrium — mean 0-5 mm Hg
Free T4 index — 4-11 Right ventricle
Triiodothyronine, free (T3) — 3.6-5.6 ng/L (5.6-8.6 Systolic — 20-25 mm Hg
Triiodothyronine, resin (T3) — 25%-35% Diastolic — 0-5 mm Hg